ENTPD1 and neoplasm: The authors further demonstrated that in the microenvironments containing CD4(+) CD73(+) T cells, B cells, or CD39(+) CD73(+) exosomes, CD73 is readily available to CD4(+) CD39(+) CD73(neg) Tregs for the production of tumor-promoting adenosine [173].